Psyadon Pharmaceuticals' Unattributed VC Round

Psyadon Pharmaceuticals raised a round of funding on November 05, 2008.

Psaydon Pharmaceuticals, formerly Ruxton Pharmaceuticals, is developing drugs to treat neurodegenerative diseases with an initial focus on glutamate transporters for ALS…

Articles about Psyadon Pharmaceuticals' Unattributed VC Round: